Display options
Cite
Qayyum T, McArdle P, Hilmy M, et al. A prospective study of the role of inflammation in bladder cancer. Curr Urol. 2013;6(4):189-93doi: 10.1159/000343537.
Qayyum, T., McArdle, P., Hilmy, M., Going, J., Orange, C., Seywright, M., Horgan, P., Underwood, M., & Edwards, J. (2013). A prospective study of the role of inflammation in bladder cancer. Current urology, 6(4), 189-93. https://doi.org/10.1159/000343537
Qayyum, Tahir, et al. "A prospective study of the role of inflammation in bladder cancer." Current urology vol. 6,4 (2013): 189-93. doi: https://doi.org/10.1159/000343537
Qayyum T, McArdle P, Hilmy M, Going J, Orange C, Seywright M, Horgan P, Underwood M, Edwards J. A prospective study of the role of inflammation in bladder cancer. Curr Urol. 2013 Feb;6(4):189-93. doi: 10.1159/000343537. Epub 2013 Feb 08. PMID: 24917741; PMCID: PMC3783284.
Copy Download .nbib Format: NLM
Share it on

Curr Urol. 2013 Feb;6(4):189-93. doi: 10.1159/000343537. Epub 2013 Feb 08.

A prospective study of the role of inflammation in bladder cancer.

Current urology

Tahir Qayyum, Peter McArdle, Mustafa Hilmy, James Going, Clare Orange, Morag Seywright, Paul Horgan, Mark Underwood, Joanne Edwards

Affiliations

  1. Institute of Cancer, College of MVLS, University of Glasgow, Western Infirmary, Glasgow, UK.
  2. Department of Urology, Royal Infirmary, Glasgow, UK.
  3. University Department of Pathology, Royal Infirmary, Glasgow, UK.
  4. Department of Pathology, Western Infirmary, Glasgow, UK.
  5. School of Medicine, College of MVLS, University of Glasgow, Royal Infirmary, Glasgow, UK.

PMID: 24917741 PMCID: PMC3783284 DOI: 10.1159/000343537

Abstract

INTRODUCTION: To examine the role of inflammation in bladder cancer, we assessed the relationship between a systemic inflammation prognostic score (modified Glasgow Prognostic Score, mGPS), the tumor inflammatory cell infiltrate as measured by the Klintrup-Makinen score and tumor necrosis with cancer specific survival in patients with bladder cancer.

MATERIALS AND METHODS: The cohort consisted of 68 bladder cancer patients, 47 with localised disease and 21 with muscle invasive disease. The mGPS response was constructed by measuring C-reactive protein and albumin concentrations and the Klintrup-Makinen score was evaluated histologically for the local inflammatory response. Pathological parameters such as grade, T stage and tumor necrosis were also assessed.

RESULTS: Median follow was 47 months and 24 patients died of their disease. On univariate analysis, T stage (p < 0.001), grade (p < 0.001) and mGPS (p = 0.002) were significant predictors of cancer specific survival. On multivariate analysis, T stage (hazard ratio 5.98, 95% confidence interval 3.18-11.24, p < 0.001) and mGPS (hazard ratio 1.78, 95% confidence interval 1.09-2.9, p = 0.02) were significant independent predictors of cancer specific survival.

CONCLUSION: A preoperative systemic inflammatory response is an independent predictor of poor cancer specific survival in patients with bladder cancer.

Keywords: Bladder cancer; C-reactive protein; Glasgow prognostic score; Inflammation; Klintrup-Makinen score

References

  1. Cancer. 2005 Aug 1;104(3):511-20 - PubMed
  2. Br J Cancer. 2003 Sep 15;89(6):1028-30 - PubMed
  3. Br J Cancer. 2006 Mar 13;94(5):637-41 - PubMed
  4. Urol Int. 2012;88(3):277-81 - PubMed
  5. Urol Int. 2010;84(4):430-5 - PubMed
  6. Br J Cancer. 2005 Feb 28;92(4):625-7 - PubMed
  7. J Pathol. 1999 Dec;189(4):487-95 - PubMed
  8. Eur J Cancer. 2005 Nov;41(17):2645-54 - PubMed
  9. BJU Int. 2008 Sep;102(6):756-61 - PubMed
  10. Nature. 2002 Dec 19-26;420(6917):860-7 - PubMed
  11. Proc Nutr Soc. 2008 Aug;67(3):257-62 - PubMed
  12. Cancer Res. 2001 Jul 1;61(13):5132-6 - PubMed
  13. BJU Int. 2011 Dec;108(11):1800-5 - PubMed
  14. Nat Rev Immunol. 2004 Aug;4(8):641-8 - PubMed
  15. Am J Surg Pathol. 1998 Dec;22(12):1435-48 - PubMed
  16. Int J Colorectal Dis. 2007 Aug;22(8):881-6 - PubMed
  17. J Pathol. 1997 Jul;182(3):318-24 - PubMed
  18. Ann Surg. 2009 May;249(5):788-93 - PubMed
  19. Cancer Res. 1998 Aug 15;58(16):3491-4 - PubMed
  20. Br J Cancer. 1999 Feb;79(5-6):991-5 - PubMed
  21. Br J Cancer. 2002 Jul 29;87(3):264-7 - PubMed
  22. Nutr Cancer. 2000;37(1):36-40 - PubMed
  23. Br J Cancer. 2006 Nov 6;95(9):1234-8 - PubMed
  24. Lancet. 1987 Jun 6;1(8545):1303-6 - PubMed
  25. Lung Cancer. 2002 Sep;37(3):235-40 - PubMed
  26. Hum Pathol. 2010 Dec;41(12):1749-57 - PubMed

Publication Types